926 results on '"Park, Hae-Sim"'
Search Results
2. Serum Galectin-10: A biomarker for persistent airflow limitation in adult asthmatics
3. Downregulation of otulin induces inflammasome activation in neutrophilic asthma
4. Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia
5. 8-Iso-prostaglandin F2α as a biomarker of type 2 low airway inflammation and remodeling in adult asthma
6. The effect of Bruton’s tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse
7. Work-related asthma in adults with severe asthma from the Korean Severe Asthma Registry (KoSAR)
8. HLA-DRB1 is associated with cefaclor-induced immediate hypersensitivity
9. Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study
10. Lactobacillus paracasei-derived extracellular vesicles alleviate neutrophilic asthma by inhibiting the JNK pathway in airway epithelium
11. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers
12. Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma
13. Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study
14. Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice
15. Real-World Effectiveness of Statin Therapy in Adult Asthma
16. Adverse Impacts of Corticosteroid Treatment on Osteoporosis/Osteopenia in Adult Asthmatics: A Retrospective ICARUS Cohort Study
17. Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma
18. Prediction of the number of asthma patients using environmental factors based on deep learning algorithms
19. Long-term efficacy of anti-IL-4 receptor antibody in a patient with aspirin-exacerbated respiratory disease and IgG4-related disease
20. Engineering bispecific T-cell engagers to deplete eosinophils for the treatment of severe eosinophilic asthma
21. Micrococcus luteus-derived extracellular vesicles attenuate neutrophilic asthma by regulating miRNAs in airway epithelial cells
22. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
23. Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice
24. Calcium ionophore-activated platelets induce eosinophil extracellular trap formation
25. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study
26. Effectiveness of Maintenance and Reliever Therapy Using Inhaled Corticosteroid–Formoterol in Asthmatics
27. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study
28. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study
29. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
30. Combined IgE neutralization and Bifidobacterium longum supplementation reduces the allergic response in models of food allergy
31. 8-Iso-prostaglandin F2α as a biomarker of T2-low airway inflammation and remodeling in adult asthma
32. Update on latex allergy: New insights into an old problem
33. Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma
34. S100A9 in adult asthmatic patients: a biomarker for neutrophilic asthma
35. Longitudinal Outcomes of Severe Asthma: Real-World Evidence of Multidimensional Analyses
36. Real-world treatment trajectories of adults with newly diagnosed asthma or COPD
37. Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma
38. Toward personalization of asthma treatment according to trigger factors
39. COVID-19, asthma, and biological therapies: What we need to know
40. Detection of circulating IgG autoantibody to FcεRIα in sera from chronic spontaneous urticaria patients
41. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
42. New targets for type 2-low asthma
43. Real-world treatment trajectories of adults with newly diagnosed asthma or COPD
44. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of YH35324, a Novel Long-Acting High-Affinity IgETrap-Fc Fusion Protein, in Atopic Subjects with a Total IgE > 700 IU/mL
45. Immune Cell-Mediated Autoimmune Responses in Severe Asthma
46. ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma
47. Occupational asthma due to cricket powder in a cricket breeder
48. Impairment and Disability Evaluations
49. Osteopontin contributes to late-onset asthma phenotypes in adult asthma patients
50. The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.